These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
162 related articles for article (PubMed ID: 35988850)
1. Macrolide therapy in Pseudomonas aeruginosa infections causes uL4 ribosomal protein mutations leading to high-level resistance. Goltermann L; Andersen KL; Johansen HK; Molin S; La Rosa R Clin Microbiol Infect; 2022 Dec; 28(12):1594-1601. PubMed ID: 35988850 [TBL] [Abstract][Full Text] [Related]
2. Macrolide therapy in Pseudomonas aeruginosa infections causes uL4 ribosomal protein mutations leading to high-level resistance: author's response. Goltermann L; Johansen HK; Molin S; La Rosa R Clin Microbiol Infect; 2022 Dec; 28(12):1667-1668. PubMed ID: 36150672 [No Abstract] [Full Text] [Related]
3. Re: 'Macrolide therapy in Pseudomonas aeruginosa infections causes uL4 ribosomal protein mutations leading to high-level resistance' by Goltermann et al. Karakonstantis S Clin Microbiol Infect; 2022 Dec; 28(12):1665-1666. PubMed ID: 36075497 [No Abstract] [Full Text] [Related]
4. Acquired resistance to macrolides in Mustafa MH; Khandekar S; Tunney MM; Elborn JS; Kahl BC; Denis O; Plésiat P; Traore H; Tulkens PM; Vanderbist F; Van Bambeke F Eur Respir J; 2017 May; 49(5):. PubMed ID: 28526799 [TBL] [Abstract][Full Text] [Related]
5. Regulatory effects of macrolides on bacterial virulence: potential role as quorum-sensing inhibitors. Tateda K; Standiford TJ; Pechere JC; Yamaguchi K Curr Pharm Des; 2004; 10(25):3055-65. PubMed ID: 15544497 [TBL] [Abstract][Full Text] [Related]
6. Characterization of Two Macrolide Resistance-Related Genes in Multidrug-Resistant Chen Q; Lu W; Zhou D; Zheng G; Liu H; Qian C; Zhou W; Lu J; Ni L; Bao Q; Li A; Xu T; Xu H Pol J Microbiol; 2020 Sep; 69(3):349-356. PubMed ID: 33574864 [TBL] [Abstract][Full Text] [Related]
7. Aminoglycoside resistance of Pseudomonas aeruginosa in cystic fibrosis results from convergent evolution in the mexZ gene. Prickett MH; Hauser AR; McColley SA; Cullina J; Potter E; Powers C; Jain M Thorax; 2017 Jan; 72(1):40-47. PubMed ID: 27325751 [TBL] [Abstract][Full Text] [Related]
8. Pseudomonas aeruginosa chromosomal beta-lactamase in patients with cystic fibrosis and chronic lung infection. Mechanism of antibiotic resistance and target of the humoral immune response. Ciofu O APMIS Suppl; 2003; (116):1-47. PubMed ID: 14692154 [TBL] [Abstract][Full Text] [Related]
9. Scorpionfish BPI is highly active against multiple drug-resistant Holzinger JM; Toelge M; Werner M; Ederer KU; Siegmund HI; Peterhoff D; Blaas SH; Gisch N; Brochhausen C; Gessner A; Bülow S Elife; 2023 Jul; 12():. PubMed ID: 37461324 [TBL] [Abstract][Full Text] [Related]
10. Macrolide antibiotics for cystic fibrosis. Southern KW; Barker PM; Solis A Cochrane Database Syst Rev; 2004; (2):CD002203. PubMed ID: 15106170 [TBL] [Abstract][Full Text] [Related]
11. Penicillin-binding protein 3 is a common adaptive target among Pseudomonas aeruginosa isolates from adult cystic fibrosis patients treated with β-lactams. Clark ST; Sinha U; Zhang Y; Wang PW; Donaldson SL; Coburn B; Waters VJ; Yau YCW; Tullis DE; Guttman DS; Hwang DM Int J Antimicrob Agents; 2019 May; 53(5):620-628. PubMed ID: 30664925 [TBL] [Abstract][Full Text] [Related]
12. Does ivacaftor interfere with the antimicrobial activity of commonly used antibiotics against Pseudomonas aeruginosa?-Results of an in vitro study. Millar BC; Rendall JC; Downey DG; Moore JE J Clin Pharm Ther; 2018 Dec; 43(6):836-843. PubMed ID: 29959786 [TBL] [Abstract][Full Text] [Related]